Navigation Links
EAU Completes Approval Process for Electrolyzed Water as Sanitation Process for Industrial Clean-in-Place Application
Date:9/15/2009

g promising results at improving animal digestion which shows signs of improved animal health and production. EAU uses terms like "green", "natural", "non-toxic" and "organic" based on our NAMSA studies that show no toxicity or cytotoxicity at levels as high as 70 ppm of HOCl. Electrolytically generated HOCl has been shown to be up to 80 times more effective at disinfecting than typically used Chlorine, depending on the type of organism and the amount present. EAU uses only water, food grade electrolytes and electricity to create all of its solutions. The active ingredients in the solutions EAU creates through electrolysis are GRAS (generally regarded as safe) approved and/or safe around humans and animals at suggested application levels. Please visit our website and sign up to be emailed our press releases and public announcements. www.eau-x.com

``Safe Harbor'' Statement under the Private Securities Litigation Reform Act of 1995

Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements may include without limitation, our expectations about the growth and the potential for the company, and Mr. Bradley's abilities to lead the company in that growth. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk associated with successfully developing our business in evolving
'/>"/>

SOURCE EAU Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related biology technology :

1. Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial
2. ACD Completes the Second Closing of Series A Financing and Initiates Services for Biomarker Validation and Companion Diagnostic Development
3. Pacific Biometrics Completes $4 Million Debt Financing
4. Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro
5. Peptimmune Completes Phase Ib Study of PI-2301 in Multiple Sclerosis Patients, and Presentation at ECTRIMS 2009
6. Cephalon Completes Acquisition of Arana Therapeutics
7. Cardinal Health Completes Biotech Acquisition
8. Beckman Coulter Completes Acquisition of Olympus Lab-Based Diagnostics Business
9. Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)
10. OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering
11. GlaxoSmithKline Completes Acquisition of Stiefel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 Aethlon Medical, Inc. (OTC Bulletin ... Schorey and Dr. Wayne Comper have ... Inc. (ESI). Both Dr. Schorey and Dr. Comper ... a wholly owned subsidiary of Aethlon Medical, was ... Hemopurifier®, a medical device being advanced as an ...
(Date:12/15/2009)... BRIARCLIFF MANOR, N.Y., Dec. 15 The ... announced that the professional society is continuing to ... is being held in Arlington, VA, April 19-21, ... society is encouraging non-members to join the organization ... event. The submission deadline is 12 AM EST, ...
(Date:12/15/2009)... , - ... the Ability of,Cardiopoietic Cells to Restore Cardiac Function ... leading Belgian biotechnology company specialising,in cell-based therapies for ... has completed, two months ahead of schedule,enrolment in ... trial of C-Cure, a,unique stem cell therapy for ...
(Date:12/14/2009)... Dyadic International, Inc. (Pink Sheets: DYAI) ("Dyadic") announced ... The Scripps Research Institute ("Scripps") by entering into ... of Dyadic,s patented and proprietary C1 fungus ("C1"). ... successful relationship between the two organizations which began ... annotate the C1 genome for the first time. ...
Breaking Biology Technology:Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5
... II still video system , Optimized Imaging ... Dye , Michelle Cayouette Jane Moores ,Stratagene Cloning ... filter with all Eagle,Eye II still video ... a single filter specifically designed,for ethidium bromide may be ...
... DNA polymerase results in greater specificity and sensitivity ... Borns Brad Scott Holly Hogrefe , ... DNA polymerase * , is the best ... long, , complex, low-copy number, or GC-rich templates. We ...
... Epitope-Tagging Vectors for Functional Analysis in Yeast ,,, ... , Quinn Lu Tanya Hosfield ... epitope-tagging vectors to express,and functionally analyze eukaryotic genes ... pESC vectors contains one of four different yeast,selective ...
Other Biology Technology:Optimized Imaging of Protein Gels Stained with Coomassie,Brilliant Blue Dye 2Optimized Imaging of Protein Gels Stained with Coomassie,Brilliant Blue Dye 3Optimized Imaging of Protein Gels Stained with Coomassie,Brilliant Blue Dye 4The Best Enzyme for the Toughest PCR Challenges Improved with New Hot-Start Feature 2The Best Enzyme for the Toughest PCR Challenges Improved with New Hot-Start Feature 3Epitope-Tagging Vectors for Functional Analysis in Yeast 2Epitope-Tagging Vectors for Functional Analysis in Yeast 3Epitope-Tagging Vectors for Functional Analysis in Yeast 4Epitope-Tagging Vectors for Functional Analysis in Yeast 5Epitope-Tagging Vectors for Functional Analysis in Yeast 6
(Date:12/15/2009)... Springer has just signed an agreement with the British ... an affiliation with the journal Biogerontology for ... will appoint one member of the Biogerontology ... issue annually. Springer will sponsor the society and ... Biogerontology on www.springerlink.com . , Biogerontology ...
(Date:12/15/2009)... December 2009 - Scientists at VIB and Ghent University ... the treatment of septic shock, the major cause of ... of nitric oxide (NO) gas in mice with septic ... the animal,s organs showed much less damage, while their ... expectations, since it is generally assumed that nitric oxide ...
(Date:12/15/2009)... 2006, a team of Spanish and American researchers found the ... Bonares, Huelva. Now they have published, for the first time, ... with the death of the young cetacean, possibly a baleen ... first discovery of the partial fossil remains of a whale ... Huelva Sands sedimentary formation, but it is the first time ...
Breaking Biology News(10 mins):Septic shock: Nitric oxide beneficial after all 2Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3Weight Loss Surgery Breaks Families Obesity Cycle 55987 1Weight Loss Surgery Breaks Families Obesity Cycle 55987 2PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration 13793 1PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration 13793 2Transdel Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 55981 1Transdel Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 55981 2
... 2007 Nanobiosym Inc., announced today that it has ... the United States Defense Threat Reduction Agency (DTRA), a ... of this award were selected after an intense competition ... and industrial labs. , Nanobiosym, and its commercial ...
... SEPTEMBER 27, 2007 New protocol and software developments are ... by making it easier for growers to use previously ... , Historically, gaps between researchers and producers, as ... relevant decisions, have all contributed to data languishing on ...
... and extraordinary $22 million gift to the University of Michigan ... one with a mission of supporting fundamental research to ... a broad range of human diseases. , The A. Alfred ... School, is named for the retail pioneer whose funding and ...
Other Biology News:Nanobiosym awarded $2 million DTRA contract 2Emphasizing the 'precision' in precision agriculture 2$22 million gift from Alfred Taubman launches new biomedical research institute 2$22 million gift from Alfred Taubman launches new biomedical research institute 3$22 million gift from Alfred Taubman launches new biomedical research institute 4
Mouse monoclonal [3B6] to HSV1 + HSV2 ICP5 Major Capsid Protein ( Abpromise for all tested applications)....
Phosphotyrosine IgG mouse monoclonal antibody: Alkaline Phosphatase conjugate...
Rabbit polyclonal to GPCR G2A ( Abpromise for all tested applications). entrezGeneID: 29933 SwissProtID: Q9UNW8...
... reagent has been developed for use ... reduction of nonspecific background staining due ... describe blocking peroxidase with hydrogen peroxide. ... in combination with additional novel components ...
Biology Products: